Subclinical Hypothyroidism in Childhood Cancer Survivors
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: In childhood cancer survivors, the most common late effect is thyroid dysfunction, most notably subclinical hypothyroidism(SCH). Our study evaluated the risk factors for persistent SCH in survivors. Materials and Methods: Survivors (n=423) were defined as patients who survived at least 2 years after cancer treatment completion. Thyroid function was assessed at this time and several years thereafter. Two groups of survivors with SCH were compared: those who regained normal thyroid function during the follow-up period (normalized group) and those who did not (persistent group). Results: Overall, 104 of the 423 survivors had SCH. SCH was observed in 26% of brain or nasopharyngeal cancer survivors (11 of 43) and 21.6% of leukemia survivors (35 of 162). Sixty-two survivors regained normal thyroid function, 30 remained as persistent SCH, and 12 were lost to follow-up. The follow-up duration was 4.03 (2.15–5.78) years. Brain or nasopharyngeal cancer and Hodgkindisease were more common in the persistent group than in the normalized group (p=0.002). More patients in the persistent group received radiation (p=0.008). Radiation to the head region was higher in this group (2394±2469 cGy) than in the normalized group (894±1591 cGy; p=0.003). On multivariable analysis, lymphoma (p=0.011), brain or nasopharyngeal cancer (p=0.039), and head radiation dose ≥1800 cGy (p=0.039) were significant risk factors for persistent SCH. Conclusion: SCH was common in childhood cancer survivors. Brain or nasopharyngeal cancer, lymphoma, and head radiation ≥1800 cGy were significant risk factors for persistent SCH.
Abstract
Purpose: In childhood cancer survivors, the most common late effect is thyroid dysfunction, most notably subclinical hypothyroidism(SCH). Our study evaluated the risk factors for persistent SCH in survivors. Materials and Methods: Survivors (n=423) were defined as patients who survived at least 2 years after cancer treatment completion. Thyroid function was assessed at this time and several years thereafter. Two groups of survivors with SCH were compared: those who regained normal thyroid function during the follow-up period (normalized group) and those who did not (persistent group). Results: Overall, 104 of the 423 survivors had SCH. SCH was observed in 26% of brain or nasopharyngeal cancer survivors (11 of 43) and 21.6% of leukemia survivors (35 of 162). Sixty-two survivors regained normal thyroid function, 30 remained as persistent SCH, and 12 were lost to follow-up. The follow-up duration was 4.03 (2.15–5.78) years. Brain or nasopharyngeal cancer and Hodgkindisease were more common in the persistent group than in the normalized group (p=0.002). More patients in the persistent group received radiation (p=0.008). Radiation to the head region was higher in this group (2394±2469 cGy) than in the normalized group (894±1591 cGy; p=0.003). On multivariable analysis, lymphoma (p=0.011), brain or nasopharyngeal cancer (p=0.039), and head radiation dose ≥1800 cGy (p=0.039) were significant risk factors for persistent SCH. Conclusion: SCH was common in childhood cancer survivors. Brain or nasopharyngeal cancer, lymphoma, and head radiation ≥1800 cGy were significant risk factors for persistent SCH.
참고문헌 (31)
- Hewitt M, "Childhood cancer survivorship: improving care and quality of life" (2003), National Academies Press
- Pui CH, "Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children’s Research Hospital, 1992 through 2007", J Clin Oncol, 30, pp.2005~2012 (2012)
- Kurt BA, "Primary care management of the childhood cancer survivor", J Pediatr, 152, pp.458~466 (2008)
- Chemaitilly W, "Endocrine complications in long-term survivors of childhood cancers", Endocr Relat Cancer, 17, pp.R141~R159 (2010)
- Nandagopal R, "Endocrine late effects of childhood cancer therapy: a report from the Children’s Oncology Group", Horm Res, 69, pp.65~74 (2008)
- Monzani A, "Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review", Eur J Endocrinol, 168, pp.R1~R11 (2012)
- Han JW, "Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention", Ann Oncol, 20, pp.1170~1177 (2009)
- Gharib H, "Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society", J Clin Endocrinol Metab, 90, pp.581~585 (2005)
- Garber JR, "Clinical practice guidelines for hypothyroidism in adults:cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association", Thyroid, 22, pp.1200~1235 (2012)
- Catli G, "Subclinical hypothyroidism in childhood and adolescense", J Pediatr Endocrinol Metab, 27, pp.1049~1057 (2014)
- Lazar L, "Natural history of thyroid function tests over 5 years in a large pediatric cohort", J Clin Endocrinol Metab, 94, pp.1678~1682 (2009)
- Ishiguro H, "Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence", J Clin Endocrinol Metab, 89, pp.5981~5986 (2004)
- Madanat LM, "The natural history of thyroid function abnormalities after treatment for childhood cancer", Eur J Cancer, 43, pp.1161~1170 (2007)
- Landier W, "Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up Guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline", J Clin Oncol, 22, pp.4979~4990 (2004)
- Cooper DS, "Subclinical thyroid disease", Lancet, 379, pp.1142~1154 (2012)
- Kim TH, "Effect of seasonal changes on the transition between subclinical hypothyroid and euthyroid status", J Clin Endocrinol Metab, 98, pp.3420~3429 (2013)
- 김예안, "Prevalence and Risk Factors of Subclinical Thyroid Disease", Endocrinology and Metabolism, 29(1), pp.20~29 (2014), 대한내분비학회
- Somwaru LL, "The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study", J Clin Endocrinol Metab, 97, pp.1962~1969 (2012)
- Meyerovitch J, "Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians", Arch Intern Med, 167, pp.1533~1538 (2007)
- Huber G, "Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies", J Clin Endocrinol Metab, 87, pp.3221~3226 (2002)
- Rodondi N, "Subclinical hypothyroidism and the risk of coronary heart disease and mortality", JAMA, 304, pp.1365~1374 (2010)
- Boekholdt SM, "Initial thyroid status and cardiovascular risk factors:the EPIC-Norfolk prospective population study", Clin Endocrinol (Oxf), 72, pp.404~410 (2010)
- Rodondi N, "Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death", Arch Intern Med, 165, pp.2460~2466 (2005)
- Chung GE, "Non-alcoholic fatty liver disease across the spectrum of hypothyroidism", J Hepatol, 57, pp.150~156 (2012)
- Baldini IM, "Psychopathological and cognitive features in subclinical hypothyroidism", Prog Neuropsychopharmacol Biol Psychiatry, 21, pp.925~935 (1997)
- 한정우, "Increasing and Worsening Late Effects in Childhood Cancer Survivors during Follow-up", Journal of Korean Medical Science, 28(5), pp.755~762 (2013), 대한의학회
- Vogelius IR, "Risk factors for radiation-induced hypothyroidism: a literaturebased meta-analysis", Cancer, 117, pp.5250~5260 (2011)
- Jereczek-Fossa BA, "Radiotherapy-induced thyroid disorders", Cancer Treat Rev, 30, pp.369~384 (2004)
- Littley MD, "Radiation-induced hypopituitarism is dose-dependent", Clin Endocrinol (Oxf), 31, pp.363~373 (1989)
- Boomsma MJ, "Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review", Radiother Oncol, 99, pp.1~5 (2011)
- Hudson MM, "Clinical ascertainment of health outcomes among adults treated for childhood cancer", JAMA, 309, pp.2371~2381 (2013)